Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

NCT03556384 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors
Sdh
GIST
Cancer

Interventions

DRUG: Temozolomide

Sponsor

Adam Burgoyne, MD, PhD